Company Celsus Therapeutics PLC (ADR) Nasdaq
Equities
US15119A2024
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 79 | 31/08/15 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 18/07/23 |
Miles Nunn
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/15 |
John Neylan
CTO | Chief Tech/Sci/R&D Officer | 70 | 07/11/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 31/05/16 |
Founder | 79 | 31/08/15 | |
Director/Board Member | 61 | 04/07/23 | |
Samir R. Patel
CEO | Chief Executive Officer | 55 | 11-28 |
Director/Board Member | 70 | 22/01/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 13,234,315,298 | 13,101,972,145 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Akari Therapeutics Plc
22 Boston Wharf Road 7th Floor
02210, Boston
+929 274 7510
http://www.akaritx.comSector
1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |